journal article·2015-12

Unanticipated stabilization of zinc-silicate glasses by addition of lanthanum: Implications for therapeutic inorganic ion delivery systems

Nancy Kilcup, Ulrike Werner-Zwanziger, Elena Tonkopi, Daniel Boyd

Publisher page

Abstract

ABSTRACT Two series of lanthanum containing zinc-silicate glasses were developed (A: 0.51SiO2–0.29Na2O–(0.20-X)ZnO–XLa2O3, 0 ≤ X ≤ 0.09; B: 0.51SiO2–0.35ZnO–(0.14-Y)Na2O–YLa2O3, 0 ≤ Y ≤ 0.14). Glasses were characterized in order to examine composition–structure–property–function relationships with a view to their potential use as therapeutic inorganic ion delivery systems. Glasses were melt synthesized and the role of lanthanum was investigated with respect to (i) glass structure based on density, glass transition temperature (Tg) and 29Si MAS-NMR, (ii) the effect on radiopacity (computed tomography) as a function of composition and (iii) the ion release characteristics under simulated physiological conditions. A linear increase in density and Tg was observed with the addition of La2O3 to each glass series. Generally, glasses demonstrated a constant molar volume, while density was observed to increase linearly with the addition of La2O3. The peak maxima of the 29Si MAS NMR spectra remained relatively unchanged by the addition of La2O3 in both glass series, but the line shapes and widths reveal modifications in the local silica structure. Radiopacity increased with La2O3: series A ranged between 1770 ± 33 and 6590 ± 89 HU and B Series B ranged between 2340 ± 54 and 9120 ± 290 HU. Series A glasses were observed to release only Na, it was also noted that increased La2O3 caused a reduction in Na+ release. Series B glasses released all constituent glass elements. Interestingly, in series B, La3 + concentration decreased over time indicating possible reprecipitation. Based on the structural data, lanthanum does not behave as a traditional network modifier and may in fact act to stabilize the network against degradation by the formation of mixed cation clusters.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Luminescence Properties of Advanced Materials · Glass properties and applications · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Bioactive dental restorative materials: a review
2. Bioactive glasses for in situ tissue regeneration10.1163/156856204323005352 ↗
3. Gene activation by bioactive glasses10.1007/s10856-006-0435-9 ↗
4. Application of strontium-doped calcium polyphosphate scaffold on angiogenesis for bone tissue engineering10.1007/s10856-013-4891-8 ↗
5. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering10.1016/j.biomaterials.2011.11.042 ↗
6. Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor10.1016/j.jnutbio.2013.08.013 ↗
7. Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity10.1016/j.biomaterials.2012.09.066 ↗
8. Effect of cobalt and chromium ions on MMP-1, TIMP-1, and TNF-alpha gene expression in human U937 macrophages: a role for tyrosine kinases10.1016/j.biomaterials.2005.02.013 ↗
9. Effects of SiO2, SrO, MgO, and ZnO dopants in tricalcium phosphates on osteoblastic Runx2 expression10.1002/jbm.a.34909 ↗
10. Bone formation controlled by biologically relevant inorganic ions: role and controlled delivery from phosphate-based glasses10.1016/j.addr.2012.05.015 ↗
11. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics10.1016/j.biomaterials.2011.01.004 ↗
12. Miguez-Pacheco, V., L.L. Hench, and A.R. Boccaccini, Bioactive glasses beyond bone and teeth: emerging applications in contact with soft tissues. Acta Biomater., 2015. 13(0): p. 1–15.10.1016/j.actbio.2014.11.004 ↗
13. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study10.1007/s00270-009-9711-7 ↗
14. Comparison of DC bead-irinotecan and DC bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer10.1007/s10856-010-4107-4 ↗
15. Chemoembolization of hepatocellular carcinoma with HepaSphere 30–60 mum. Safety and efficacy study10.1007/s00270-013-0777-x ↗
16. Radiopaque microspheres for improved transarterial chemical embolization (TACE)10.1016/j.jconrel.2011.08.132 ↗
17. Development of “Imageable” beads for transcatheter embolotherapy10.1016/j.jvir.2010.02.031 ↗
18. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization10.1097/01.RVI.0000195323.46152.B3 ↗
19. Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer10.1007/s00270-010-9794-1 ↗
20. DC Bead™ Drug Delivery Embolisation System INSTRUCTIONS FOR USE. [cited 2015 March 17, 2015]; Available from: http://www.btg-im.com/uploads/document_r/English-%28TM%29-CN00103.5 164.2 598.1.pdf.
21. Mixture designs to assess composition–structure–property relationships in SiO(2)-CaO-ZnO-La(2)O(3)-TiO(2)-MgO-SrO-Na(2)O glasses: potential materials for embolization10.1177/0885328212455834 ↗
22. Predicting the thermal responses and radiopacity of multicomponent zinc-silicate bioglasses: a focus on ZnO, La2O3, SiO2 and TiO210.1016/j.jnoncrysol.2012.08.024 ↗
23. Heffeter, P., et al., Resistance against novel anticancer metal compounds: differences and similarities. Drug Resist. Updat., 2008. 11(1–2): p. 1–16.10.1016/j.drup.2008.02.002 ↗
24. Metal complexes of natural melophlins and their cytotoxic and antibiotic activities10.1016/j.jinorgbio.2008.09.005 ↗
25. Lanthanum citrate induces anoikis of hela cells10.1016/j.canlet.2009.05.018 ↗
26. Proteomic analysis of lanthanum citrate-induced apoptosis in human cervical carcinoma SiHa cells10.1007/s10534-010-9368-3 ↗
27. Telomerase-mediated apoptosis of chicken lymphoblastoid tumor cell line by lanthanum chloride10.1007/s12011-011-9027-8 ↗
28. Cytotoxic and genotoxic effects of the quercetin/lanthanum complex on human cervical carcinoma cells in vitro10.2478/10004-1254-62-2011-2122 ↗
29. Formation and properties of sodium lanthanum silicate-glasses
30. Structural role of La2O3 in La2O3–CaO–Na2O-SiO2 glasses
31. Molieres, E., et al., Chemical durability of lanthanum-enriched borosilicate glass. Int. J. Appl. Glas. Sci., 2013. 4(4): p. 383–394.10.1111/ijag.12054 ↗
32. Cation clustering and formation of free oxide ions in sodium and potassium lanthanum silicate glasses: nuclear magnetic resonance and Raman spectroscopic findings10.1016/S0022-3093(98)00838-2 ↗
33. Chemoembolization of hepatocellular carcinoma10.1055/s-0033-1333648 ↗
34. Local-structure of alkaline-earth boroaluminate crystals and glasses.1., Crystal chemical concepts structural predictions and comparisons to known crystal-structures10.1111/j.1151-2916.1991.tb04123.x ↗
35. Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 bioglass conditioned medium in the absence of osteogenic supplements10.1016/j.biomaterials.2009.03.019 ↗
36. Shelby · 2005
37. Shear modulus, heat capacity, viscosity and structural relaxation time of Na2O–Al2O3–SiO2 and Na2O–Fe2O3–Al2O3–SiO2 melts10.1007/s00269-010-0362-7 ↗
38. Thermal properties, density and structure of percalcic and peraluminus CaO–Al2O3–SiO2 glasses10.1016/j.jnoncrysol.2014.12.019 ↗
39. Chapter 4 29Si NMR, in Pergamon Materials Series, J.D.M. Kenneth and E.S. Mark, Editors. 2002, Pergamon. p. 201–268.10.1016/S1470-1804(02)80005-0 ↗
40. Characterisation of commercial ionomer glasses using magic angle nuclear magnetic resonance (MAS-NMR)10.1016/j.biomaterials.2003.10.074 ↗
41. Glass formation and structure–property-composition relations of the RE2O3–Al2O3–SiO2 (RE=La, Y, Lu, Sc) systems10.1111/j.1551-2916.2011.04548.x ↗
42. Solid-state high-resolution si-29 chemical-shifts in silicates10.1021/j150652a015 ↗
43. Si-29 MAS NMR-spectroscopy of tectozincosilicates10.1021/j100101a010 ↗
44. Identification of multiple structural species in silicate-glasses by Si-29 NMR10.1038/330465a0 ↗
45. Influence of lanthanum on borosilicate glass structure: a multinuclear MAS and MQMAS NMR investigation10.1016/j.jnoncrysol.2013.05.042 ↗
46. The atomic arrangement in glass10.1021/ja01349a006 ↗
47. Qualitative and quantitative structure–property relationships analysis of multicomponent potential bioglasses10.1021/jp046631n ↗
48. Kahlenberg, V. and H. Kruger, LaAlSiO5 and apatite-type La-9.71 (Si-0.8 Al0.19O4)(6)O-2 — the crystal structures of two synthetic lanthanum alumosilicates. Solid State Sci., 2004. 6(6): p. 553–560.10.1016/S1293-2558(04)00090-1 ↗
49. Hurt, J.C. and C.J. Phillips, Structural role of zinc oxide in glasses in system Na2O–ZnO–SiO2. Journal of the American Ceramic Society, 1970. 53(5): p. 269-&.10.1111/j.1151-2916.1970.tb12091.x ↗
50. Structure–property relationships in multicomponent oxide glasses10.1016/S1631-0748(02)01459-5 ↗
51. Chemical durability
52. Influence of the non-bridging oxygen groups on the bioactivity of silicate glasses10.1023/A:1021174912802 ↗
53. Structure of boroaluminosilicate glasses: impact of [Al2O3]/[SiO2] ratio on the structural role of sodium10.1103/PhysRevB.86.054203 ↗
54. Effects of gamma-irradiation and accelerated aging on composition–structure–property relationships for radiopaque embolic microspheres10.1016/j.jnoncrysol.2014.05.016 ↗
55. Kehoe, S., R. Abraham, and D. Boyd, Unilateral renal artery embolization in Yucutan miniswine with imageable embolic microspheres. Journal of Vascular and Interventional Radiology. 26(2): p. S79–S80.10.1016/j.jvir.2014.12.221 ↗